Total neoadjuvant therapy with split-course hypofraction radiotherapy combined with CAPOX and envafolimab followed by local excision for locally advanced very low rectal cancer (TRACE-LE): An open-label, single-arm, multicenter, phase II trial

被引：0
|
作者：
Jiang, Weizhong
Chi, Pan
Tao, Kaixiong
Xu, Dongbo
Yang, Chunkang
Zheng, Rong
Xu, Benhua
Huang, Ying
Chen, Zhifen
Huang, Shenghui
Xu, Zongbin
机构：
[1] Fujian Med Univ, Dept Colorectal Surg, Union Hosp, Fuzhou, Fujian, Peoples R China
[2] Huazhong Univ Sci & Technol, Union Hosp, Med Coll, Wuhan, Peoples R China
[3] Fujian Med Univ, Longyan Affiliated Hosp, Longyan, Peoples R China
[4] Fujian Prov Canc Hosp, Fuzhou, Peoples R China
[5] Fujian Med Univ, Dept Radiat Oncol, Union Hosp, Fuzhou, Fujian, Peoples R China
[6] Fujian Med Univ, Dept Colorectal Surg, Union Hosp, Fuzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS3647
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: an open-label, single-arm, phase II trial
    Chen, Jie
    Li, Chen
    Cao, Yuanjie
    Zhu, Li
    Zhang, Bailin
    You, Jinqiang
    Hou, Hailing
    Wang, Jing
    Yuan, Zhiyong
    BMC CANCER, 2022, 22 (01)
  • [22] Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: an open-label, single-arm, phase II trial
    Jie Chen
    Chen Li
    Yuanjie Cao
    Li Zhu
    Bailin Zhang
    Jinqiang You
    Hailing Hou
    Jing Wang
    Zhiyong Yuan
    BMC Cancer, 22
  • [23] Dose escalation of preoperative short-course radiotherapy followed by neoadjuvant chemotherapy in locally advanced rectal cancer: protocol for an open-label, single-centre, phase I clinical trial
    Zhang, Meng-xia
    Li, Xiao-bo
    Guan, Bing-jie
    Guan, Guo-xian
    Lin, Xiao-yan
    Wu, Xiao-dong
    Chi, Pan
    Xu, Ben-hua
    BMJ OPEN, 2019, 9 (03):
  • [24] Preoperative (neoadjuvant) therapy with tislelizumab for locally advanced colorectal cancer with high microsatellite instability or deficient mismatch repair: An open-label, single-arm, multicenter phase II study.
    Ding, Ke-Feng
    Chen, Gong
    Ye, Yao
    Liu, Yue
    Sun, Yanlai
    Gao, Yang
    Zhang, Jingdong
    Wei, Shaozhong
    Li, Cong
    Li, Dandan
    Zhou, Yanbing
    Liu, Mulin
    Zhang, Juan
    Zhang, Lilin
    Kong, Dalu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [25] Neoadjuvant short-course radiotherapy followed by chemotherapy plus camrelizumab versus long-course chemoradiotherapy followed by chemotherapy for patients with locally advanced rectal cancer: A randomized, multicenter, open-label phase 3 trial (Union)
    Lin, Zhenyu
    Zhang, Peng
    Hou, Zhiguo
    Tao, Kaixiong
    Zhang, Tao
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk (“ugly”) locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT)
    K. van den Berg
    D. P. Schaap
    E. L. K. Voogt
    T. E. Buffart
    H. M. W. Verheul
    J. W. B. de Groot
    C. Verhoef
    J. Melenhorst
    J. M. L. Roodhart
    J. H. W. de Wilt
    H. L. van Westreenen
    A. G. J. Aalbers
    M. van ‘t Veer
    C. A. M. Marijnen
    J. Vincent
    L. H. J. Simkens
    N. A. J. B. Peters
    M. Berbée
    I. M. Werter
    P. Snaebjornsson
    H. M. U. Peulen
    I. G. van Lijnschoten
    M. J. Roef
    G. A. P. Nieuwenhuijzen
    J. G. Bloemen
    J. M. W. E. Willems
    G. J. M. Creemers
    J. Nederend
    H. J. T. Rutten
    J. W. A. Burger
    BMC Cancer, 22
  • [27] Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ("ugly") locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT)
    van den Berg, K.
    Schaap, D. P.
    Voogt, E. L. K.
    Buffart, T. E.
    Verheul, H. M. W.
    de Groot, J. W. B.
    Verhoef, C.
    Melenhorst, J.
    Roodhart, J. M. L.
    de Wilt, J. H. W.
    van Westreenen, H. L.
    Aalbers, A. G. J.
    Veer, M. van't
    Marijnen, C. A. M.
    Vincent, J.
    Simkens, L. H. J.
    Peters, N. A. J. B.
    Berbee, M.
    Werter, I. M.
    Snaebjornsson, P.
    Peulen, H. M. U.
    van Lijnschoten, I. G.
    Roef, M. J.
    Nieuwenhuijzen, G. A. P.
    Bloemen, J. G.
    Willems, J. M. W. E.
    Creemers, G. J. M.
    Nederend, J.
    Rutten, H. J. T.
    Burger, J. W. A.
    BMC CANCER, 2022, 22 (01)
  • [28] Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial
    Shi, Jinming
    Li, Ning
    Tang, Yuan
    Jiang, Liming
    Yang, Lin
    Wang, Shulian
    Song, Yongwen
    Liu, Yueping
    Fang, Hui
    Lu, Ningning
    Qi, Shunan
    Chen, Bo
    Li, Ziyu
    Liu, Shixin
    Wang, Jun
    Wang, Wenling
    Zhu, Suyu
    Yang, Jialin
    Li, Yexiong
    Zhao, Dongbing
    Jin, Jing
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [29] Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial
    Jinming Shi
    Ning Li
    Yuan Tang
    Liming Jiang
    Lin Yang
    Shulian Wang
    Yongwen Song
    Yueping Liu
    Hui Fang
    Ningning Lu
    Shunan Qi
    Bo Chen
    Ziyu Li
    Shixin Liu
    Jun Wang
    Wenling Wang
    Suyu Zhu
    Jialin Yang
    Yexiong Li
    Dongbing Zhao
    Jing Jin
    BMC Gastroenterology, 22
  • [30] Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial
    Lee, Jii Bum
    Kim, Han Sang
    Jung, Inkyung
    Shin, Sang Joon
    Beom, Seung Hoon
    Chang, Jee Suk
    Koom, Woong Sub
    Kim, Tae Il
    Hur, Hyuk
    Min, Byung Soh
    Kim, Nam Kyu
    Park, Sohee
    Jeong, Seung-Yong
    Baek, Jeong-Heum
    Kim, Seon Hahn
    Lim, Joon Seok
    Lee, Kang Young
    Ahn, Joong Bae
    TRIALS, 2020, 21 (01)
12345